← Back to headlines
Sanofi Halts Late-Stage Trial for CIDP Therapy, Dianthus Shares Drop
Dianthus shares fell after Sanofi announced it was halting a late-stage trial for a CIDP (chronic inflammatory demyelinating polyneuropathy) therapy due to efficacy concerns.
10 Jun, 11:36 — 10 Jun, 11:36
Sources
Showing 1 of 1 sources
